Home > Financial Ratios > WANBURY

WANBURY
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for WANBURY
Please provide your vote to see the results

WANBURY Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 9.34203.06-34.5980.29-16.93

What is the latest Core EBITDA Growth ratio of WANBURY ?

The latest Core EBITDA Growth ratio of WANBURY is 9.34 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar20259.34
Mar2024203.06
Mar2023-34.59
Mar202280.29
Mar2021-16.93

How is Core EBITDA Growth of WANBURY Trending?

Years Core EBITDA Growth % Change
Mar2025 9.34
-95.40
Mar2024 203.06
Positive
Mar2023 -34.59
Negative
Mar2022 80.29
Positive
Mar2021 -16.93 -

Other Financial Ratios of WANBURY


Compare Core EBITDA Growth ratio of peers of WANBURY

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WANBURY ₹899.4 Cr -2% -0.5% -5.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹451,591.0 Cr 3.2% 12.4% 11.5% Stock Analytics
DIVIS LABORATORIES ₹183,512.0 Cr 1.8% 11% 10.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹150,850.0 Cr 3.8% 6.7% 35.5% Stock Analytics
CIPLA ₹113,884.0 Cr 6.2% 13.9% -4.6% Stock Analytics
DR REDDYS LABORATORIES ₹111,339.0 Cr 5.4% 8% 9.1% Stock Analytics


WANBURY Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WANBURY

-2%

-0.5%

-5.9%

SENSEX

0.9%

-3.6%

-7.3%


You may also like the below Video Courses